The Utility of the Oncotype DX Test for Breast Cancer Patients in an Australian Multidisciplinary Setting

Table 2

Adjuvant chemoendocrine therapy based on recurrence score.

	All patients n = 71	RS < 11 n = 10	RS 11–25 n = 45	RS > 25 n = 16
Type of adjuvant therapy, n (%)
No endocrine therapy or chemotherapy	1 (2)	0 (0)	1 (2)	0 (0)
Endocrine only	54 (76)	10 (100)	43 (96)	1 (6)
Endocrine and chemotherapy	16 (22)	0 (0)	1 (2)	15 (94)